AIXI Explodes 51% Pre-Market on Apple Patent Play — But the Delisting Clock Is Still Ticking

Pre-market: April 10, 2026, 9:11 AM ET

Key Data

• Price: $1.50 (+51.5% pre-market)
• Prior Close: $0.99
• Volume: 81.6M
• Float: ~25M shares
• Market Cap: ~$13.3M

AIXI is ripping again. After last week’s explosive 500%+ rally on China’s Supreme Court upholding its AI patents against Apple — followed by a pullback to $0.99 at yesterday’s close — the stock is surging 51% pre-market to $1.50 this morning on heavy volume. Over 81 million shares have already changed hands before the bell.

Let’s be clear about what actually happened here. China’s Supreme Court formally rejected Apple’s appeal to invalidate Xiao-I’s patents, affirming their validity in a final, binding ruling. That’s the catalyst. But the company itself warned investors that neither financial recovery nor ultimate litigation success is assured. The patent validity question? Settled. The damages? Still completely unknown.

The mechanics are textbook micro-cap momentum. AIXI has virtually no Wall Street analyst coverage and extremely thin trading volume, meaning modest buying pressure generates outsized price moves. Volume exploded to over 300 million shares on the initial patent news last week. After pulling back to $0.99 yesterday, this morning’s pre-market rip to $1.50 is catching late shorts and sidelined traders off guard.

Here’s the critical context traders need. AIXI received dual Nasdaq deficiency notices in December — failing to maintain the $1 minimum bid price from November 3 through December 15, 2025. They have until June 16, 2026 to regain compliance or face delisting. The stock closed at $0.99 yesterday — one penny short of compliance. Today’s $1.50 pre-market print changes the math entirely. If AIXI can stay above $1 for 10 consecutive trading days, the immediate delisting threat goes away.

That’s a massive “if” in micro-cap land. The float is thin enough that whale selling can crater the price in minutes. We’ve already seen wild swings from last week’s highs.

The fundamentals paint a grim picture behind the patent theatrics. The company’s balance sheet shows $101.3M in total liabilities. Net income hit negative $2.8M annually. Book value per share sits at -$0.98. This isn’t a business story — it’s a litigation lottery ticket with momentum characteristics.

The patent victory isn’t meaningless — it could enhance licensing opportunities or strengthen negotiating power in China’s AI ecosystem. But there’s no timeline for damages, no guarantee of financial compensation, and the underlying business still burns cash while fighting to stay listed.

For traders watching this, the levels are stark. The $1.00 Nasdaq compliance threshold is the line that matters most — 10 consecutive days above it cures the deficiency. Yesterday’s $0.99 close showed how fragile the hold is. Today’s $1.50 pre-market shows the stock can get there, but sustaining it is another story entirely. Below $1 and the delisting clock resumes with less than 70 days to cure.

The setup is high-octane but dangerous. Patent wins don’t fix balance sheets, and micro-cap momentum cuts both ways. Last week proved this stock can rip faces. The pullback to $0.99 proved gravity works. This morning’s 51% surge proves the cycle can repeat. Trade accordingly.

This report represents analysis of publicly available information and does not constitute investment advice.